Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection
about
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cellsOncolytic virus therapy: A new era of cancer treatment at dawnClinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activityExploring Reovirus Plasticity for Improving Its Use as Oncolytic VirusDiminished reovirus capsid stability alters disease pathogenesis and littermate transmissionOncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancerModification of mammalian reoviruses for use as oncolytic agentsA phase I trial of single-agent reolysin in patients with relapsed multiple myelomaPermissiveness of human cancer cells to oncolytic bovine herpesvirus 1 is mediated in part by KRAS activityOncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic virusesReovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysisIsolation of reovirus T3D mutants capable of infecting human tumor cells independent of junction adhesion molecule-A.Attenuated reovirus displays oncolysis with reduced host toxicityReovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samplesOncolytic reovirus in canine mast cell tumor.Effect of human activated NRAS on replication of delNS1 H5N1 influenza virus in MDCK cells.Oncolytic bluetongue viruses: promise, progress, and perspectivesGlycan engagement dictates hydrocephalus induction by serotype 1 reovirus.Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells.Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacyMechanisms of reovirus-induced cell death and tissue injury: role of apoptosis and virus-induced perturbation of host-cell signaling and transcription factor activation.PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.Oncolytic adenoviruses - selective retargeting to tumor cells.Reovirus receptors, cell entry, and proapoptotic signaling.Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation.The sweet spot: defining virus-sialic acid interactions.Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy.Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer.Coronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastomaIntravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors.Reovirus-based therapy for cancer.Progress of oncolytic viruses in sarcomas.Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present).Evolution of oncolytic viruses: novel strategies for cancer treatment.Oncolytic viral therapy: targeting cancer stem cellsActivated ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells.Virotherapy in cancer
P2860
Q21245717-7FF2B6B0-4285-45CD-B6BD-407CB78B16DAQ26739714-90591B90-0AAD-4EED-87B0-04DA9A123383Q26750568-2FD5E6FA-3528-4089-90C6-EE2495AB3D44Q26771799-ED30622E-2CDE-4E92-B474-14F044F29DC9Q27321066-7A2A70EB-A576-4BBA-9FEC-CDE163033476Q28078939-D196B40D-C63E-44F0-9599-38C6646338E8Q28264900-9CBC1A01-49B5-4C66-B829-C7530BC74FC1Q33418048-15FDD508-ED2A-4E47-B06D-909329C2D9E1Q33743847-6C3C9346-4E0A-4087-86AC-04CEF7FB3448Q33924550-E86552B5-A855-4F45-806A-1E6DCDD8EFB7Q34393001-0BFDF808-883E-4B4A-826F-BDC81FF3AB84Q34452682-E79F3CEF-D871-42AD-BCFA-F0BB93E8792AQ34460916-F216D5EF-19FC-410B-9636-363BE3384A91Q34543808-A9FAB8B2-3EB8-4333-B21A-E46F7DF93D8CQ34763999-A2F70B5D-E96C-4EF9-9553-94263066C622Q35000631-D065713A-423F-4E6A-8DC5-F6D9477FBA21Q35040110-98F06A35-B255-4DD3-BF45-B47FF6C5883EQ35084491-60F8C914-D0AB-486C-8431-9129074DD97DQ35172332-F4BAD99A-4793-4958-B979-551FAC828D95Q35216380-BCD1EF32-4F22-439F-85C6-8AE06625E1C1Q35635226-DC9B3B35-9E8D-4D30-A21D-5AAED49BB643Q35657822-D8AA6D35-F8F1-477A-A2C1-70A6A7F86280Q36085535-4F9B3B8E-262F-4A01-BBD8-062424B2A20DQ36252554-00C24B5C-E959-4CF1-9257-51124818AD35Q36318166-B834DD81-0849-4096-8CE0-A51EF3283F8DQ36318189-21745F7A-0AF4-4F93-AE8D-7FDA18242477Q36494593-CA907A61-D1CF-4395-A4C5-E80A6DE546C7Q36673201-F2A92387-1D8D-4E6B-8DDD-BA18B32651B2Q36685206-320C11D9-7F80-4A14-930E-5F93F0FB2D94Q36766052-EA9B964F-87EE-41B3-B6D2-5293D6F97BB2Q37062074-BA5874B4-66DA-411A-AAFD-EE495E72CD7BQ37256658-8538DA89-FF7A-465D-B05A-7B07042DB3F6Q37364079-4CA4F43C-78C6-4C29-9E3C-4138AD260A54Q37519640-C32E508F-0EBC-4C75-8505-CA6DA08C572AQ37982449-1CF089D3-5DD9-4F19-A8BF-41D62E5DAEEFQ38046230-AA091273-4F20-45CD-B179-2663615EFAC2Q38159802-C1CC541D-A305-41B8-A6C5-B045E58F2F6DQ38212255-8A6657DD-3536-4857-812A-96712974387EQ38229052-889721F4-F25C-4DC9-B854-8757D0540C84Q38253646-F6012947-589A-42AB-A026-C032906FCB3D
P2860
Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reovirus oncolysis: the Ras/Ra ...... siveness to reovirus infection
@en
Reovirus oncolysis: the Ras/Ra ...... iveness to reovirus infection.
@nl
type
label
Reovirus oncolysis: the Ras/Ra ...... siveness to reovirus infection
@en
Reovirus oncolysis: the Ras/Ra ...... iveness to reovirus infection.
@nl
prefLabel
Reovirus oncolysis: the Ras/Ra ...... siveness to reovirus infection
@en
Reovirus oncolysis: the Ras/Ra ...... iveness to reovirus infection.
@nl
P2093
P2860
P356
P1476
Reovirus oncolysis: the Ras/Ra ...... siveness to reovirus infection
@en
P2093
An-Dao Yang
Kara L Norman
Kensuke Hirasawa
Michael A Shields
Patrick W K Lee
P2860
P304
11099-11104
P356
10.1073/PNAS.0404310101
P407
P577
2004-07-19T00:00:00Z